SGUT2isaproteininhumansthatfaciuitatesaucosereabsorotion inthekidnev; SGT2inhibitorsbockthe
reabsorptionofaucoseinthekidney.increaseglucoseexcretionanduowver blood glucoselevels.SGT2isa
low-affinity,high-capacity glucosetransporteruocated intheproximattubuleinthekidneys;
responsiblefor
90%ofqlucosereabsorption.InhibitionofSGLT2ueadstothedecrease inbloodalucoseduetothe increase in
renaualucoseexcretion.Themechanismof actionofthisnew cass of druasasooffersfurtheraucosecontrot
bvallowinaincreasedinsuunsensitivitv anduotakeofaucoseinthemusceceus.decreased quconeoaenesis
andimorovedfirst-phaseinsuuinreleasefromthebetacels.vaqinauyeast infectionsandurinarytract
infectionsarethemostcommmn side-effects.Thev alsocausesianificantlowerinaofHbAlcwithoutincreased
riskof hypoqtycaemia.reductionof bodyweightandreductionofsystolicblood pressure.In addition,the
EMPA-REGtriat showed thatempaglifiozin significantty reduced deaths among individuals with type2
diabetesandestablishedcardiovascular diseasewhencompared wth placebo.seeExternauinks)
@1MINENDOCRINE
